According to filings with the U.S. Securities and Exchange Commission, XYMOGEN is raising $4,000,000.00 in new funding. Sources indicate that as part of senior management Chairman and Chief Executive Officer, Brian Blackburn played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About XYMOGEN
XYMOGEN, a family-owned health sciences company headquartered in Orlando, Fla., has been providing high-quality dietary supplements to licensed health care practitioners for more than a quarter century. The nutraceutical company has introduced numerous innovations to the functional medicine community; its Medical Board of Advisors consists of clinical practitioners who are industry experts in a broad range of specialties. XYMOGENs strength as a company has been reinforced nine of the last ten years, as it was recognized again in 2016 by Inc. magazine as one of the 5000 fastest-growing, best-run, most innovative and most inspiring private companies in America. The company’s 136,000 square-foot manufacturing facility is GMP (good manufacturing practices) and GMP for Sport Athletic Banned Substances Program registered by NSF International and TGA Certified.

To learn more about XYMOGEN, visit http://www.xymogen.com/

Contact:
Brian Blackburn, Chairman and Chief Executive Officer
407-445-0203
https://www.linkedin.com/in/brian-blackburn-b4719310/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.